Results 251 to 260 of about 586,857 (269)

Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102

Clinical Colorectal Cancer, 2017
Kentaro Yamazaki, Tomoya Yokota
exaly  

Chemiluminescence μTAS for the determination of atropine and pethidine

Talanta, 2002
Gillian M Greenway
exaly  

The microstructure, tensile properties, and creep behavior of AZ91, AS52 and TAS652 alloy

Journal of Alloys and Compounds, 2010
Yong Ho Park, Ik Min Park
exaly  

The Toronto Alexithymia Scale (TAS-20): A measure of general psychological distress

Journal of Research in Personality, 2009
Daniel Leising
exaly  

Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer

Annals of Oncology, 2017
Marta Schirripa, Dongyun Yang, Sabina Murgioni   +2 more
exaly  

Industrie und Handel im OECD‐Bereich, Firmen aus 22 Ländern in einem Buch. Darmstadt, Juli 1966 (TA). TELEUROPE, 39. Ausgabe, 1966, ca. 3000 S., Preis DM 50.—

Fette, Seifen, Anstrichmittel, 1966
openaire   +1 more source

Examining the predictive validity of SUS-TAS with maximum parsimony in developing island countries

Journal of Sustainable Tourism, 2018
Manuel Alector Ribeiro, Patricia Pinto, joão Silva   +2 more
exaly  

A multicenter phase II study of TAS-102 monotherapy in patients with pre-treated advanced gastric cancer (EPOC1201)

European Journal of Cancer, 2016
Hideaki Bando, Toshihiko Doi, Kei Muro
exaly  

TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial)

European Journal of Cancer, 2019
Tatsuya Ioka, Makoto Ueno, Joon Oh Park
exaly